摘要

The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts towards the structure-mutagenicity or structure-genotoxicity relationships have been undertaken. The current perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, and their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.
原文英語
頁(從 - 到)2851-2893
頁數43
期刊Journal of Medicinal Chemistry
62
發行號6
DOIs
出版狀態已發佈 - 三月 28 2019

指紋

Antitubercular Agents
Antiparasitic Agents
Pharmaceutical Chemistry
Prodrugs
Therapeutic Uses
Pharmaceutical Preparations
Antineoplastic Agents
Hypoxia
Surveys and Questionnaires

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

引用此文

Nitro-Group-Containing Drugs. / Nepali, Kunal; Lee, Hsueh Yun; Liou, Jing Ping.

於: Journal of Medicinal Chemistry, 卷 62, 編號 6, 28.03.2019, p. 2851-2893.

研究成果: 雜誌貢獻回顧型文獻

@article{feb753b198114cab8c0b7f13e2f25525,
title = "Nitro-Group-Containing Drugs",
abstract = "The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts towards the structure-mutagenicity or structure-genotoxicity relationships have been undertaken. The current perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, and their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.",
author = "Kunal Nepali and Lee, {Hsueh Yun} and Liou, {Jing Ping}",
year = "2019",
month = "3",
day = "28",
doi = "10.1021/acs.jmedchem.8b00147",
language = "English",
volume = "62",
pages = "2851--2893",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Nitro-Group-Containing Drugs

AU - Nepali, Kunal

AU - Lee, Hsueh Yun

AU - Liou, Jing Ping

PY - 2019/3/28

Y1 - 2019/3/28

N2 - The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts towards the structure-mutagenicity or structure-genotoxicity relationships have been undertaken. The current perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, and their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.

AB - The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts towards the structure-mutagenicity or structure-genotoxicity relationships have been undertaken. The current perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, and their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.

UR - http://www.scopus.com/inward/record.url?scp=85056485313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056485313&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b00147

DO - 10.1021/acs.jmedchem.8b00147

M3 - Review article

AN - SCOPUS:85056485313

VL - 62

SP - 2851

EP - 2893

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -